Fei Mao
10PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Jul 31, 2024
Discovery of Novel Azaphenothiazine Derivatives to Suppress Endometrial Cancer by Targeting GRP75 to Impair Its Interaction with IP3R and Mitochondrial Ca2+ Homeostasis.Xianwu Ling, Jiahui Zhang, Lingyi Song
|Mar 25, 2024
Drug Repurposing of ACT001 to Discover Novel Promising Sulfide Prodrugs with Improved Safety and Potent Activity for Neutrophil-Mediated Antifungal Immunotherapy.Xiangran Lu, Rongrong Wang, Yao Yu
|Sep 08, 2022
Pro-senescence neddylation inhibitor combined with a senescence activated β-galactosidase prodrug to selectively target cancer cells.Shuaishuai Ni, Qian Liu, Xin Chen
|Feb 17, 2022
Drug Repurposing of Quisinostat to Discover Novel Plasmodium falciparum HDAC1 Inhibitors with Enhanced Triple-Stage Antimalarial Activity and Improved Safety.Manjiong Wang, Tongke Tang, Ruoxi Li
|Apr 08, 2021
Fangchinoline suppresses conjunctival melanoma by directly binding FUBP2 and inhibiting the homologous recombination pathway.Keting Bao, Yongyun Li, Jinlian Wei
|Feb 05, 2021
Discovery of Novel Plasmodium falciparum HDAC1 Inhibitors with Dual-Stage Antimalarial Potency and Improved Safety Based on the Clinical Anticancer Drug Candidate Quisinostat.Ruoxi Li, Dazheng Ling, Tongke Tang
Pageof 2
